Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.

Pruis, M A

Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer. [electronic resource] - Lung cancer (Amsterdam, Netherlands) 02 2020 - 46-54 p. digital

Publication Type: Journal Article

1872-8332

10.1016/j.lungcan.2019.11.010 doi


Adenocarcinoma of Lung--drug therapy
Aged
Aged, 80 and over
Biomarkers, Tumor--genetics
Carcinoma, Non-Small-Cell Lung--drug therapy
Crizotinib--therapeutic use
DNA, Neoplasm--analysis
Diagnostic Tests, Routine
Exons
Female
Follow-Up Studies
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged
Mutation
Prognosis
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins c-met--antagonists & inhibitors
Retrospective Studies
Survival Rate